Chief Executive Officer
PhD in Pharmaceutics and Executive MBA, Stockholm School of Economics. Over 25 years of experience of product development from innovation to market, such as formulation development, clinical trials, manufacturing and business development. Has founded 2 company
.
Head of QA and Chief Pharmaceutical Officer Member of the Board, Co-founder
A licensed pharmacist and Associate Professor in Clinical Pharmacy. Since 2015, he has been a pioneer in implementing 3D-printed medicines for extemporaneous manufacturing in human medicine. Has founded 2 companies.
Chairman of the Board
Chief Scientific Officer, Co-founder
Professor of Molecular Pharmaceutics at Uppsala University, and an internationally recognized leader in pharmaceutical formulation. With over 25 years of experience, Christel brings unparalleled expertise and a global network spanning academia and industry. Has founded 4 companies.
Chief Medical Officer, Co-founder
Professor of Veterinary Pharmacology, DiplECVIM-CA (Oncology) at the Swedish University of Agricultural Sciences. Henrik is a world renowned expert in comparative clinical oncology with over 25 years of research experience and significant contributions to veterinary and human clinical trials. Founded 3 companies.
Member of the Board
Sverre Bengtsson is a life science veteran with more than 30 years of experience in the life science industry. Sverre co-founded the software company Viedoc Technologies, the company behind the groundbreaking, smart, and feature-rich eClinical system Viedoc. He is also an active angel investor, having invested in roughly 30 life science companies.
Mattias Paulsson, Feb 3, 2026
https://lifescience.stuns.se/3d-printing-in-stockholm-uppsala/
Questions? Please contact us on information@extempharma.com
Mattias Paulsson, Jan16, 2026
Questions? Please contact us on information@extempharma.com
Mattias Paulsson, Dec 18, 2025
Read more here: AIP 2025 – Research – Staff – Uppsala University
Questions? Please contact us on information@extempharma.com
Mattias Paulsson, Oct 29, 2025
This recognition highlights the strong innovation potential of our 3D-printed medicines and our mission to accelerate access to high-quality clinical trial materials.
We are proud to contribute to the future of pharmaceutical manufacturing in Sweden as an innovative startup company.
Questions? Please contact us on information@extempharma.com
Mattias Paulsson, Sep 20, 2025
Extem Pharma has successfully completed its directed share issue. The round was fully subscribed, marking an important step in accelerating the build-up of our production site and advancing our business development.
Questions? Please contact us on information@extempharma.com
Mattias Paulsson, Aug 2025
At our company, two of our founders were recently featured on Swedish public television (SVT), showcasing 3D‑printing for on‑demand, customized pharmaceuticals. From lab‑made “vanilla” to “tuna‑flavored” medicines, this technology makes it possible to design doses and flavours that match the individual patient needs.
Vanilj eller tonfisk – här i labbet skapas 3D-printade läkemedel | SVT Nyheter
Mattias Paulsson, July 2025
Extem Pharma has signed a lease agreement for its first manufacturing site, located at Vallongatan 1 in Uppsala. The facility will be equipped for GMP-compliant small-scale pharmaceutical production and 3D printing of personalised medicines.
Mattias Paulsson, July 2025
Up to 37% of oral drugs given to children are manipulated before use — split, crushed, or dispersed — leading to dosing errors and safety risks.
One of our co-founders is the lead author of a recent scientific review highlighting these challenges and the need for personalised manufacturing in paediatrics.
Extem Pharma offers a better way: age-appropriate, 3D-printed medicines tailored to each patient.
Mattias Paulsson, May 2025
We’re so happy to announce our collaboration with Craft Health, a pioneering company based in Singapore specializing in 3D printing of pharmaceuticals.
This partnership strengthens Extem Pharma’s commitment to personalized medicine and supports our mission to bring innovative, patient-friendly drug formulations to the market.
Together, we aim to accelerate the development and adoption of 3D-printed dosage forms in clinical practice. Please read more about Craft Health here.
Questions? Please contact us on information@extempharma.com
Mattias Paulsson, March 2025
One year ago, we officially launched Extem Pharma - and what a year it's been! We are also proud to announce that we have been awarded the Business Prize Bona Postulata! Thank you to everyone who has supported on this journey!